Nektar Therapeutics (NKTR)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Drug Delivery

Drugs

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

4

(1)

27

0

0

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
14-Jun-24 6:02 PM View:	14-Jun-24 Sale ($23.40K)	Chess Robert Chairman of the Board Director		Nektar Therapeutics - NKTR	(7%) 278.97K to 259.47K	0	0	--	--	Show Txns Hide Txns

20-Nov-24 8:36 PM View:	19-Nov-24 Sale ($16.44K)	Robin Howard W President & CEO Director		Nektar Therapeutics - NKTR	(8%) 900.33K to 832.49K	0	0	--	--	Show Txns Hide Txns

20-Nov-24 8:37 PM View:	19-Nov-24 Sale ($7.86K)	Zalevsky Jonathan Chief R&D Officer		Nektar Therapeutics - NKTR	(11%) 274.04K to 243.02K	0	0	--	--	Show Txns Hide Txns

20-Nov-24 8:36 PM View:	19-Nov-24 Sale ($6.47K)	Wilson Mark Andrew Chief Legal Officer		Nektar Therapeutics - NKTR	(10%) 244.28K to 218.86K	0	0	--	--	Show Txns Hide Txns

13-May-24 4:36 PM View:	10-May-24 Sale ($99.63K)	Deep Track Capital, Lp 10% Owner		Nektar Therapeutics - NKTR	0% 18.4M to 18.34M	0	0	--	--	Show Txns Hide Txns